Clinical Trial

Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
There are two parts to this trial. First, to compare the rate of myopia progression of spectacle films using Spatio Temporal Optic Phase (S.T.O.P.®) technology that provide a dynamic optical cue against single vision spectacle lenses. Second, to compare the rate of myopia progression of spectacle films using S.T.O.P.® technology that provide a dynamic optical cue against spectacle films using S.T.O.P.® technology that provide a static optical cue. A dynamic optical cue is one that changes, and a static optical cue is one that does not change.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-11-15; most recent amendment 2026-06-15.
Status change: Recruiting → Active, Not Recruiting 2026-06-15
Status change: Not Yet Recruiting → Recruiting 2024-02-01
Trial Details
NCT Number NCT06137560
Lead Sponsor nthalmic Pty Ltd
Collaborators: Zhong Jing Wei Shi (Suzhou) Optical Technology Ltd.
Conditions Myopia
Enrollment 210 participants
Start Date 2023-12-22
Primary Completion 2028-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-17